ReNeuron Group Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 8

Employees

  • Stock Symbol
  • RNUGF

Stock Symbol

  • Investments
  • 1

ReNeuron Group General Information

Description

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

Contact Information

Formerly Known As
Mf59657 PLC, Mf59657 Limited
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Pencoed Business Park
  • Pencoed
  • Bridgend CF35 5HY
  • Wales, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • Pencoed Business Park
  • Pencoed
  • Bridgend CF35 5HY
  • Wales, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReNeuron Group Stock Performance

As of 27-Jun-2024, ReNeuron Group’s current market cap is $2.44M with 57.2M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.44M 57.2M 2.12K

ReNeuron Group Financials Summary

As of 31-Mar-2025, ReNeuron Group has a trailing 12-month revenue of $1.08M.

In Thousands,
USD
TTM 31-Mar-2025 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023
EV (3,337) (4,723)
Revenue 1,082 1,082 1,775 638
EBITDA 1,104 1,104 (4,056) (7,854)
Net Income (6,511)
Total Assets 2,125 2,125 4,832 11,945
Total Debt 0 0 0 521
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ReNeuron Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ReNeuron Group‘s full profile, request access.

Request a free trial

ReNeuron Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical devel
Drug Discovery
Bridgend, United Kingdom
8 As of 2025

Turku, Finland
 

Gothenburg, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ReNeuron Group Competitors (67)

One of ReNeuron Group’s 67 competitors is Faron Pharmaceuticals, a Corporation company based in Turku, Finland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Faron Pharmaceuticals Corporation Turku, Finland
Alzinova Corporation Gothenburg, Sweden
Mesoblast Corporation Melbourne, Australia
Minerva Neurosciences Formerly VC-backed Burlington, MA
Amarantus BioScience Holdings Formerly Accelerator/Incubator backed New York, NY
You’re viewing 5 of 67 competitors. Get the full list »

ReNeuron Group Patents

ReNeuron Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1465493-A1 Cultured and encapsulated pancreatic stem cells Inactive 21-Dec-2001
EP-1465493-A4 Cultured and encapsulated pancreatic stem cells Inactive 21-Dec-2001
EP-1301589-A1 Culturing pancreatic stem cells having a specified, intermediate stage of development Inactive 30-Jun-2000
EP-1301589-A4 Culturing pancreatic stem cells having a specified, intermediate stage of development Inactive 30-Jun-2000 C12N5/0676

ReNeuron Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ReNeuron Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ReNeuron Group‘s full profile, request access.

Request a free trial

ReNeuron Group Acquisitions (1)

ReNeuron Group’s most recent deal was a Merger/Acquisition with AmCyte for . The deal was made on 27-Jul-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AmCyte 27-Jul-2007 Merger/Acquisition Drug Delivery
To view ReNeuron Group’s complete acquisitions history, request access »

ReNeuron Group ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view ReNeuron Group’s complete esg history, request access »

ReNeuron Group FAQs

  • When was ReNeuron Group founded?

    ReNeuron Group was founded in 1997.

  • Where is ReNeuron Group headquartered?

    ReNeuron Group is headquartered in Bridgend, United Kingdom.

  • What is the size of ReNeuron Group?

    ReNeuron Group has 8 total employees.

  • What industry is ReNeuron Group in?

    ReNeuron Group’s primary industry is Drug Discovery.

  • Is ReNeuron Group a private or public company?

    ReNeuron Group is a Public company.

  • What is ReNeuron Group’s stock symbol?

    The ticker symbol for ReNeuron Group is RNUGF.

  • What is the current market cap of ReNeuron Group?

    The current market capitalization of ReNeuron Group is $2.44M.

  • What is ReNeuron Group’s current revenue?

    The trailing twelve month revenue for ReNeuron Group is $1.08M.

  • Who are ReNeuron Group’s competitors?

    Faron Pharmaceuticals, Alzinova, Mesoblast, Minerva Neurosciences, and Amarantus BioScience Holdings are some of the 67 competitors of ReNeuron Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process